UK markets close in 5 hours 40 minutes

Guangdong Biolight Meditech Co., Ltd. (300246.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
6.49-0.24 (-3.57%)
At close: 03:04PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 1.78B
Enterprise value 1.88B
Trailing P/E 20.73
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.55
Price/book (mrq)1.23
Enterprise value/revenue 1.48
Enterprise value/EBITDA 18.16

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-38.48%
S&P500 52-week change 322.64%
52-week high 312.79
52-week low 35.07
50-day moving average 37.02
200-day moving average 310.09

Share statistics

Avg vol (3-month) 36.46M
Avg vol (10-day) 35.05M
Shares outstanding 5264.58M
Implied shares outstanding 6264.58M
Float 8185.22M
% held by insiders 133.42%
% held by institutions 14.17%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.2
Forward annual dividend yield 42.97%
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 41.37
Payout ratio 461.60%
Dividend date 3N/A
Ex-dividend date 425 May 2023
Last split factor 21.5:1
Last split date 325 May 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -7.95%
Operating margin (ttm)1.92%

Management effectiveness

Return on assets (ttm)1.04%
Return on equity (ttm)-5.81%

Income statement

Revenue (ttm)1.12B
Revenue per share (ttm)3.90
Quarterly revenue growth (yoy)-22.60%
Gross profit (ttm)N/A
EBITDA 94.8M
Net income avi to common (ttm)-88.72M
Diluted EPS (ttm)0.32
Quarterly earnings growth (yoy)-86.60%

Balance sheet

Total cash (mrq)591.84M
Total cash per share (mrq)2.23
Total debt (mrq)690.68M
Total debt/equity (mrq)49.84%
Current ratio (mrq)1.86
Book value per share (mrq)4.93

Cash flow statement

Operating cash flow (ttm)168.32M
Levered free cash flow (ttm)72.82M